KindredBio

KindredBio is a California-based veterinary biopharmaceutical company that develops and commercializes protein pet therapeutics for dogs, cats and horses. Read more

Richard Chin's photo - President & CEO of KindredBio

President & CEO

Richard Chin

CEO Approval Rating

82/100

KINDREDBIO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Virbac is KindredBio's #1 competitor. Virbac's headquarters is in Carros, Other, and was founded in 1968. Like KindredBio, Virbac also works within the Pharmaceuticals sector. Virbac generates 2,610% of KindredBio's revenue.

Merck Animal Health is one of KindredBio's top rivals. Merck Animal Health was founded in Madison, New Jersey} in 1940. Merck Animal Health operates in the Pharmaceuticals industry. Compared to KindredBio, Merck Animal Health generates $4.8B more revenue.

Zoetis is one of KindredBio's top competitors. Zoetis is a Public company that was founded in 1952 in Parsippany, New Jersey. Zoetis is in the Pharmaceuticals industry. Compared to KindredBio, Zoetis has 11,154 more employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is VetStem a competitor of KindredBio?

KindredBio Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$44M

KindredBio's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 2B. Over the last four quarters, KindredBio's revenue has decreased by 93.9%. Specifically, in Q1 2021's revenue was $2.4M; in Q4 2020, it was $ < 1M; in Q3 2020, it was $1M; in Q2 2020, KindredBio's revenue was $39.6M.

KindredBio Acquisitions

No recent acquisitions found related to KindredBio

KindredBio Funding History

Since KindredBio was founded in 2012, it has participated in 6 rounds of funding. In total KindredBio has raised $114.7M. KindredBio's last funding round was on Oct 2019 for a total of $50.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Oct 2019
$50M

Solar Capital Partners, LLC

Equity
Jan 2014
--
IPO
Dec 2013
$52.5M
-
Equity
Aug 2013
$5.3M
-
Equity
Jun 2013
$5.9M
-

Since KindredBio was founded in 2012, it has participated in 6 rounds of funding. In total KindredBio has raised $114.7M. KindredBio's last funding round was on Oct 2019 for a total of $50.0M

KindredBio Investments

No recent investments found related to KindredBio

KindredBio News

April 21, 2021Benzinga

Kindred's New IL-31 Antibody Shows Improved Shelf Life In PK Study For Canine Dermatitis

Kindred Biosciences Inc (NASDAQ: KIN) has announced positive results from the pharmacokinetic study (... See more »
March 17, 2021Post Online Media

Kindred Biosciences Q4 net revenues $1.0 million

Kindred Biosciences announced financial results for the fourth quarter and full year ended December 3... See more »
March 16, 2021BioSpace

Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving ... See more »
March 8, 2021MarketScreener

Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial Results

(marketscreener.com) SAN FRANCISCO, March 8, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. , a bioph... See more »
February 25, 2021Benzinga

Kindred Biosciences Submits Efficacy Data For KIND-030 As Prophylactic Option In US

Kindred Biosciences Inc (NASDAQ: KIN) has submitted efficacy data to support the prophylactic indicat... See more »
February 24, 2021Veterinary Practice News

Horse pyrexia drug gets distribution deal

An injectable drug designed to control fever in horses has landed a North American distribution deal.... See more »

KindredBio Press Releases

February 25, 2021centralcharts

Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic Indication

Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic Indi... See more »
February 16, 2021centralcharts

Kindred Biosciences to Present at the BofA Securities Animal Health Virtual Summit

Kindred Biosciences to Present at the BofA Securities Animal Health Virtual Summit PR Newswire SAN FR... See more »
November 11, 2020PR Newswire

Kindred Biosciences to Participate in Stifel Virtual Healthcare Conference and A.G.P. Virtual Healthcare Symposium

SAN FRANCISCO, Nov. 11, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceut... See more »
November 9, 2020PR Newswire

Kindred Biosciences Announces Third Quarter 2020 Financial Results

SAN FRANCISCO, Nov. 9, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceuti... See more »
October 28, 2020PR Newswire

Kindred Biosciences to Announce Third Quarter 2020 Financial Results

SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceut... See more »
September 9, 2020PR Newswire

Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth Conference

SAN FRANCISCO, Sept. 9, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceut... See more »
April 15, 2020centralcharts

Kindred Biosciences Announces Completion of Mirataz (mirtazapine transdermal ointment) Transaction

Kindred Biosciences Announces Completion of Mirataz® (mirtazapine transdermal ointment) Transaction P... See more »

Social Media

KindredBio Headquarters

1555 Bayshore Hwy Suite 226

Burlingame, California94010

888-608-2542

Driving Directions »

Trending Companies

KindredBio Summary

ABOUT

Overview

KindredBio is a California-based veterinary biopharmaceutical company that develops and commercializes protein pet therapeutics for dogs, cats and horses. KindredBio was founded in 2012. KindredBio's headquarters is located in Burlingame, California, ...

CEO

KindredBio's President & CEO, Richard Chin, currently has an approval rating of 82%. KindredBio's primary competitors are Virbac, Merck Animal Health & Zoetis.

Frequently Asked Questions about KindredBio

  1. When was KindredBio founded?

    KindredBio was founded in 2012
  2. Who is KindredBio's CEO?

    KindredBio's CEO is Richard Chin
  3. How much revenue does KindredBio generate?

    KindredBio generates $44M in revenue
  4. How much funding does KindredBio have?

    KindredBio has historically raised $114.7M in funding
  1. Where is KindredBio's headquarters?

    KindredBio's headquarters is in Burlingame California, USA
  2. How many employees does KindredBio have?

    KindredBio has 146 employees
  3. What sector does KindredBio operate in?

    KindredBio is in Pharmaceuticals
  4. Who are KindredBio's competitors?

    KindredBio's top competitors are Virbac, Merck Animal Health, Zoetis